Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The novel COronaVIrus Disease 19 (COVID-19) outbreak has impacted daily activities in nearly 210 countries and territories worldwide. In Ecuador, the city of Guayaquil has nearly two-thirds of the COVID-positive patients in the country and nearly 40% of infected individuals are health-care related personnel. Nonemergent, emergent and urgent endoscopic procedures are necessary to be performed during the COVID-19 pandemic. Several experiences in the management of the endoscopic unit during the pandemic has been proposed. We aimed to prospectively evaluate a strict protocol for preventing potential nosocomial infection of COVID-19.
Description: COVID-19 infection in the staff documented via PCR
Measure: Rate of COVID-19 nosocomial infection among the endoscopy staff at the end of the 30-days study. Time: through study completion, an average of 30 daysDescription: Endoscopic records of patients treated during the COVID-19 protocol
Measure: Numbers of patients evaluated and treated during the COVID-19 outbreak in the endoscopy unit at the end of the 30-days study. Time: through study completion, an average 30 daysDescription: technical success of endoscopic procedures
Measure: Technical success rate of endoscopic procedures during the 30-days study period. Time: through study completion, an average 30 daysDescription: serum levels of IgG and IgM against COVID-19
Measure: IgG and IgM against COVID-19 in the endoscopy staff measured at the end of the study. Time: through study completion, an average 30 daysDescription: adverse events of endoscopic procedures
Measure: Adverse events rate of endoscopic procedures during the 30-days Time: through study completion, an average 30 days